Orchid Pharma Limited has informed the Exchange about change in Management regarding intimation for re-appointment of Independent Directors of Orchid Pharma Limited
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Orchid Pharma's Board of Directors has approved the re-appointment of three Non-Executive Independent Directors — Dr. Dharam Vir (DIN: 08771224), Mr. Manoj Kumar Goyal (DIN: 06361663), and Ms. Tanu Singla (DIN: 08774132) — for a second tenure of five years, effective June 29, 2025 to June 28, 2030. The company confirmed there are no inter-se relationships among the directors and that all appointments comply with SEBI's eligibility norms. Profiles reveal varied expertise: Dr. Dharam Vir in synthetic organic/medicinal chemistry, Mr. Manoj Goyal in taxation, audit, and finance, and Ms. Tanu Singla in company secretarial and legal matters. Orchid Pharma is currently part of the Dhanuka Group.
This is a routine corporate governance announcement ensuring board continuity with no material change for shareholders. It is unlikely to have any meaningful impact on the stock price.